Drug profile · INN
pergolide mesylate
PERGOLIDE MESYLATE
pergolide mesylate (PERGOLIDE MESYLATE) is a dopamine receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — pergolide mesylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 1
- Data quality
- 0.89
Quick answer
pergolide mesylate (PERGOLIDE MESYLATE) is a dopamine receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine receptor agonist
Primary target: Dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is pergolide mesylate?
pergolide mesylate (PERGOLIDE MESYLATE) is a dopamine receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pergolide mesylate?
PERGOLIDE MESYLATE is a marketed brand name for pergolide mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pergolide mesylate?
pergolide mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.